10-week Leucine Supplementation in Cerebral Palsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03668548

Recruitment Status : Unknown

Verified August 2018 by St Mary's University College.
Recruitment status was: Enrolling by invitation

First Posted : September 12, 2018

Last Update Posted : September 12, 2018

Sponsor:

Collaborator:

University of Gloucestershire

Information provided by (Responsible Party):

St Mary's University College

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	October 22, 2018
Estimated Study Completion Date :	October 22, 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Theis N, Brown MA, Wood P, Waldron M. Leucine Supplementation Increases Muscle Strength and Volume, Reduces Inflammation, and Affects Wellbeing in Adults and Adolescents with Cerebral Palsy. J Nutr. 2021 Jan 4;151(1):59-64. doi: 10.1093/jn/nxaa006.

To Top